AZD-3289 is a potent BACE1 inhibitor with potential Alzheimers disease inhibitory activity. The application of AZD-3289 is intended to slow the pathological progression of Alzheimers disease by inhibiting the production of beta-amyloid protein. The development of AZD-3289 responds to the need to reduce neurodegenerative changes associated with Alzheimers disease. As a BACE1 inhibitor, AZD-3289 can effectively reduce the accumulation of beta-amyloid peptide in the brain, which may improve cognitive function[1].
Molecular Weight:
467.39
CAS Number:
[1227163-49-6]
Formula:
C24H14F5N5
Target:
Endogenous Metabolite
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
